The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemia

Diana Abbott,Evan Cherry,Maria L. Amaya,Christine McMahon,Marc Schwartz,Amanda Winters,Jeffrey Schowinsky,Craig T. Jordan,Clayton A. Smith,Jonathan A. Gutman,Daniel A. Pollyea

The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemia

2020

Diana Abbott
Evan Cherry
Maria L. Amaya
Christine McMahon
Marc Schwartz
Amanda Winters
Jeffrey Schowinsky
Craig T. Jordan
Clayton A. Smith
Jonathan A. Gutman
Daniel A. Pollyea

Widely-used response criteria, conditional upon count recovery, were developed for acute myeloid leukemia (AML) in the context of intensive chemotherapy (IC). Extending these definitions to continu...

Keywords:

Internal medicine
Venetoclax
Myeloid leukemia
intensive chemotherapy
newly diagnosed
Oncology
Azacitidine
response criteria
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations